130 related articles for article (PubMed ID: 5812585)
1. Phase II study of hexamethylmelamine (NSC 13875).
Wilson WL; Schroeder JM; Bisel HF; Mrazek R; Hummel RP
Cancer; 1969 Jan; 23(1):132-6. PubMed ID: 5812585
[No Abstract] [Full Text] [Related]
2. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
Kholodnyi MD; Mindlin SS
Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329
[No Abstract] [Full Text] [Related]
3. Antitumor drug toxicity: implications for response and for survival.
Nahhas WA; Hall TC; Sherman CD; Savlov ED
Am J Med Sci; 1969 Oct; 258(4):245-59. PubMed ID: 5823461
[No Abstract] [Full Text] [Related]
4. Toxicity study of BCNU (NSC-409962) given orally.
Lessner HE; Vogler WR
Cancer Chemother Rep; 1974; 58(3):407-11. PubMed ID: 4601671
[No Abstract] [Full Text] [Related]
5. [Iatrogenic pathology in hematology].
Brunetaud JM; Coudoux P; Geoffroy H
Maroc Med; 1972 Mar; 52(555):135-47. PubMed ID: 4114478
[No Abstract] [Full Text] [Related]
6. Clinical experiences with dibromodulcitol (NSC-104800) in solid tumors.
Phillips RW; Brook J
Cancer Chemother Rep; 1971 Dec; 55(5):567-73. PubMed ID: 4946081
[No Abstract] [Full Text] [Related]
7. Streptozotocin in the treatment of cancer: phase II study.
Strolinsky DC; Sadoff L; Braunwald J; Bateman JR
Cancer; 1972 Jul; 30(1):61-7. PubMed ID: 4261143
[No Abstract] [Full Text] [Related]
8. Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer.
Talley RW; Samson MK; Brownlee RW; Samhouri AM; Fraile RJ; Baker LH
Eur J Cancer (1965); 1981 Mar; 17(3):337-43. PubMed ID: 6455296
[No Abstract] [Full Text] [Related]
9. The efficacy of animal studies in predicting clinical toxicity of cancer chemotherapeutic drugs.
Schein P; Anderson T
Int J Clin Pharmacol; 1973 Nov; 8(3):228-38. PubMed ID: 4203921
[No Abstract] [Full Text] [Related]
10. Initial clinical trial of dibromodulcitol (NSC-104800) in patients with advanced cancer.
Keyes JW; Selawry OS; Hansen HH
Cancer Chemother Rep; 1971 Dec; 55(5):583-9. PubMed ID: 5003621
[No Abstract] [Full Text] [Related]
11. Effect of hexamethylmelamine (NSC-13875) on small cell carcinoma of the lung (phase II study).
Takita H; Didolkar MS
Cancer Chemother Rep; 1974; 58(3):371-4. PubMed ID: 4601667
[No Abstract] [Full Text] [Related]
12. Phase I study of dibromodulcitol (NSC-104800).
Andrews NC; Weiss AJ; Ansfield FJ; Rochlin DB; Mason JH
Cancer Chemother Rep; 1971 Feb; 55(1):61-5. PubMed ID: 5121653
[No Abstract] [Full Text] [Related]
13. Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.
Muss H; Bundy BN; DiSaia PJ; Twiggs LB
Cancer Treat Rep; 1986 Oct; 70(10):1231-2. PubMed ID: 3530450
[No Abstract] [Full Text] [Related]
14. BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease, lymphosarcoma, and reticulum cell sarcoma.
Rege VB; Owens AH
Cancer Chemother Rep; 1974; 58(3):383-92. PubMed ID: 4601668
[No Abstract] [Full Text] [Related]
15. Clinical experience with mitomycin C (NSC-26980).
Whittington RM; Close HP
Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
[No Abstract] [Full Text] [Related]
16. Hematologic complications of cancer chemotherapy.
Hoagland HC
Semin Oncol; 1982 Mar; 9(1):95-102. PubMed ID: 7071611
[No Abstract] [Full Text] [Related]
17. [Hematological control in the treatment of epilepsy].
Wierzbowska A; Radomska M; Kolodziej A
Neurol Neurochir Pol; 1971; 5(3):383-6. PubMed ID: 5116791
[No Abstract] [Full Text] [Related]
18. [Association of antineoplastic agents in the treatment of lung neoplasms. A study of 173 cases].
Decroix G; Sors C
Sem Hop; 1968 Nov; 44(48):2933-9. PubMed ID: 4305734
[No Abstract] [Full Text] [Related]
19. [Complications of chemotherapy at the bedside].
Jaouen C; Riou P; Hartmann O
Soins; 1979 Aug 5-20; 24(15-16):61-6. PubMed ID: 158218
[No Abstract] [Full Text] [Related]
20. Clinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors.
Robustelli della Cuna G; Paoletti P; Bernardo G; Knerich R; Butti G; Cuzzoni Q
Neurosurgery; 1982 Sep; 11(3):408-11. PubMed ID: 6290930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
